AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Albaad Massuot Yitzhak Ltd.

Investor Presentation May 21, 2024

6630_rns_2024-05-21_0548221a-d4ac-41aa-9d60-63065be80a70.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

May

2024

Financial Results Overview Q1.2024

1

FORWARD LOOKING STATEMENT

Legal disclaimer Important notice

This presentation (the "Presentation") is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any shares of Albaad Massuot Yitzhak LTD. (the "Company") or any of its affiliated entities.

This presentation contains partial information from the public reports of the Company under the Israeli Securities Law 5728-1968 (the "Securities Law"), which can be accessed on the Israeli Securities Authority's website, www.magna.isa.gov.il. A review of this presentation is not a substitute for a review of the detailed reports of the Company under the Securities Law and is not meant to replace or qualify them; rather, the presentation is prepared merely for the convenience of the reader, with the understanding that the detailed reports are being reviewed simultaneously.

Everything stated in this Presentation with respect to an analysis of the Company's business is merely a summary and any forwardlooking statements involve risks and uncertainties. These statements include descriptions regarding the intent, belief or current expectations of the Company. Such forward-looking statements are not guarantees of future results, performance or achievements and are based on current expectations, estimations, and assumptions, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performances or achievements of the Company may differ materially from what is or may be expressed or implied in this presentation due to a variety of factors, many of which are beyond the Company's control, including, without limitation, certain risk factors contained in the Company's reports. The Company disclaims any obligation or commitment to update these forward-looking statements to reflect new information, future events or developments or changes in expectations, estimates, projections and assumptions or otherwise.

Q1.2024 COMPANY MAIN HIGHLIGHTS CONCLUDING Q1.2024 WITH

  • SALES INCREASE OF 0.7% TO 416M NIS
  • GROSS PROFIT MARGIN improved to 20.2%
  • EBIT* INCREASE OF 46% TO 25.7M NIS
  • EBITDA** INCREASE OF 26% TO 48.3M NIS
  • NET PROFIT** INCREASE OF 37% TO 9.5M NIS
  • OPERATING Cash Flow 31.5M NIS
  • NET DEBT DECREASE TO 526M NIS

SALES & EBITDA* TRENDS 2022-2024

QUARTERLY BASIS (000 NIS)

Sales EBITDA

NET DEBT TO EBITDA* TRENDS 2022-2024

QUARTERLY BASIS (000 NIS)

Net Debt EBITDA (LTM)

HIGHLIGHTS

Q1.2024 Results VS. Last year (000 NIS)

+1% Sales Sales in original currency -3.4% +46% Operating Profit

+52% including others

+26%

EBITDA +45% inc. discontinued operation

+37%

Net Profit +13 M inc. discontinued operation

Q1
2024
Q1
2023
Var Var
%
Sales 416
222
,
413
293
,
2
929
,
0
7%
EBIT 25
755
,
16
925
,
8
830
,
52
2%
EBIT
(Before
Others)
25
755
,
17
637
,
8
118
,
46
0%
EBITDA
(Continued
operation)
48
278
,
38
348
,
9
930
,
25
9%
EBITDA 48
626
,
33
440
,
15
186
,
45
4%
Profit
Net
(Continued
operation)
9
512
,
6
950
,
2
562
,
36
9%
Profit
Net
14
501
,
1
419
,
13
082
,

SALES & EBIT* BY DIVISION

Q1.2024 VS. Last year (000 NIS)

Sales *
EBIT
Q1
2024
Q1
2023
Var
%
(Org.)
Var
%
Q1
2024
Q1
2023
Albaad
Europe
326
010
,
302
129
,
7
9%
3
0%
23
087
,
7
878
,
%
from
sales
7.1% 2
6%
Albaad
IL
55
829
,
56
372
,
(1
0%)
(2
5%)
3
073
,
(1
408)
,
from
%
sales
5.5% (2
.5%)
Fabric
Albaad
IL
044
77
,
99
342
,
(22
4%)
(26
0%)
3
089
,
13
312
,
from
sales
%
4
0%
13
4%
Albaad
Fem
IL
49
136
,
67
384
,
(27
1%)
(29
8%)
1
292
,
9
636
,
%
from
sales
2
6%
14
3%
Intercompany (91
797)
,
(111
934)
,
732 (5
979)
,
HeadQuarter
Others
&
(5
518)
,
(5
802)
,
Company
Total
416
222
,
413
293
,
7%
0
4%
-3
25
755
,
17
637
,
%
from
sales
6
2%
4
3%
Other
Income/Expenses
(712)
Total
Company
416
222
,
413
293
,
0
7%
-3
4%
25
755
,
16
925
,
from
%
sales
6
2%
4
1%

BALANCE SHEET

AS OF 31.03.2024 VS. 31.12.2023 (000 NIS)

31
03
2024
from
%
total
31
12
2023
from
%
total
18M
Cash on hand
Cash
and
cash
equivalents
17
921
,
1% 19
133
,
1%
Trade
Receivables
218
944
,
14% 213
956
,
14%
Inventory 321
982
,
21% 328
969
,
21%
Other
Current
Assets
34
925
,
2% 32
184
,
2%
7M Reduction of inventory Current
Total
Assets
593
772
,
38% 594
242
,
38%
Non
Current
Assets
969
348
,
62% 988
361
,
62%
Total
Assets
1
563
120
,
,
100% 1
582
603
,
,
100%
417M Equity Credit
banking
&
institutions
408
829
,
26% 392
243
,
25%
Trade
Payables
213
289
,
14% 222
718
,
14%
Current
Total
Liabilities
563
733
,
47% 713
183
,
45%
27%
Equity from total
balance sheet
Total
Long-Term
Liabilities
412
976
,
26% 466
178
,
29%
Equity 416
581
,
27% 403
242
,
25%
Total
liabilities
1
563
120
,
,
100% 1
582
603
,
,
100%

INNOVATION & FUTURE GROWTH Green product line in Dimona - the next generation

  • o Green hybrid production line that enables production in both paper technology and green non-woven technology
  • o The Hydrofine® Products from the new hybrid line will serve both flushable MTT wipes as well as traditional baby, cosmetic and cleaning wipes
  • o All Hydrofine® Products are made from 100% natural, plant based components
  • o Production is expected during H2 2024
  • o Approximately 158M NIS invested up to March 2024 from total budget of about 200M NIS

SUMMARY

Improving Banks Covenants*

o Net Liabilities to EBITDA Ratio 1.91 (Covenant <3.6) / Tangible Equity Ratio 27.4% (Covenant >21%)

Completing USA project

  • o Selling/clearing all wipes, fabric and chemicals inventory
  • o Moving to a sub-tenant lease agreement, reducing the rental area & maintenance cost
  • o Receiving the deal Escrow of \$1m
  • o Recognizing from the above 5.2m NIS net profit

Maintaining positive performance for EBITDA Growth & Operating Cash Flow

  • o Inventory reduction of 7m NIS since Dec 2023, reduction of 68m NIS vs. Q1.2023
  • o Operating Cash Flow of 31.5m NIS
  • o Free Cash Flow** of 15.5m NIS including Dimona line 2 investments

** FCF 15.5 m = Operating CF 31.5 m + Leasing liability repayment (-7.5 m) Interest (-9.6 m) + CAPEX (-18.1 m)

FURTHER STRENGTHENING & FUTURE GROWTH

Further Finance Strengthening

  • o Optimizing our debt structure, given our achievement in exceeding bank covenants
  • o Closing Sale & Lease Back transaction of Dimona facility

Future Growth

  • o Dimona Green hybrid production line as milestone for growth, aligns with our sustainability strategy
  • o Continues efforts to develop Spunlace-based tampon after getting patent approval
  • o Focusing on new customers & Innovation products expanding Europe sales teams
  • o Establish production excellence project to enhance efficiency

THANK YOU

12

Talk to a Data Expert

Have a question? We'll get back to you promptly.